Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Provident Bank announced the promotion of Annamaria Vitelli to Executive Vice President, Chief Wealth Officer of Provident Bank, and President of its wealth management subsidiary, Beacon Trust. Vitelli will lead strategic growth initiatives across Provident's wealth management business, collaborating with business divisions to enhance integrated fi…
BIO-key International's Chairman and CEO will present at the RedChip Future Tech Investor Conference, highlighting the company's significant revenue growth and anticipated profitability in the first half of 2026. The company, a leader in biometric authentication and identity access management, expects 1H 2026 revenues to increase by 50% compared to…
Innio, the Munich-based maker of gas engines and distributed power systems, raised $2.43 billion in an upsized initial public offering and is due to begin trading in the U.S. later on Thursday. Backing from investors attracted to companies supplying the physical infrastructure for AI - particularly data-center power equipment - helped drive demand.…
HSBC is maintaining an aggressive allocation to risk assets but has been answering repeated client questions on what might trigger a shift to a bearish stance. Chief Multi-Asset Strategist Max Kettner says common concerns such as near-term U.S. earnings, geopolitics and front-end interest-rate moves rank low, while two higher-priority risks - broad…
A poll of foreign exchange analysts conducted May 29 to June 3 shows the Canadian dollar is expected to strengthen modestly against the U.S. dollar over the next year if Canada's economy stabilizes and there is headway in the review of the continental trade pact. Short-term gains hinge on resolution of trade uncertainties and an improvement in dome…
RBC Capital Markets has started coverage of Sylvania Platinum Ltd with an "outperform" rating and a 175 pence price target, implying roughly 106% upside from the current share price of 92 pence. The broker points to a robust free cash flow profile, a sum-of-the-parts adjusted NAV of $563 million (167p per share), and a key Thaba joint venture as pr…
Meredith S. Weil, Chief Financial Officer and Director at TFS Financial CORP (NASDAQ:TFSL), engaged in significant transactions involving the company's common stock on June 2, 2026. These filings detail both sales of existing shares and substantial acquisitions via option exercises. The movements occurred against a backdrop of current market valuat…
David Stevens Hooker, a director at Northpointe Bancshares Inc. (NPB), executed multiple sales of the company's common stock in early June 2026. These insider transactions occurred against a backdrop of recent financial reporting for NPB, which noted strong profitability and improved asset quality despite a decline in net interest income. The analy…
Morgan Stanley expects U.S. natural gas prices to continue recovering through the third quarter, supported by rising LNG export flows and increased power demand, but warns of potential oversupply pressures in 2027 as associated gas from the Permian and new pipeline capacity come online. The bank adjusted its 2026 price outlook modestly lower while …
Overseas buyers have tilted toward Indian government paper maturing in under five years, seizing relative value as markets increasingly price a tightening cycle. Shorter-end yields spiked on inflation worries tied to the Iran war and energy, prompting a rotation that left long-end yields more exposed to future repricing.
An Istanbul court has handed Fenerbahce chairman Sadettin Saran a prison term of two years and six months after finding him guilty of encouraging illegal betting, a decision announced shortly before the club's scheduled congress to elect a new leader. The court also convicted his brother, Kenan Saran, on the same charge. Sadettin Saran has denied w…
Alkami (ALKT) looks primed for a re-rating after a large institutional purchase, strong recent revenue growth and talk of a shareholder vote around a buyback. The balance of improving fundamentals and continued execution risk makes this a medium-risk, long-term trade: entry $16.70, stop $14.10, target $24.00 over roughly 180 trading days.
Nasdaq futures fell sharply in early trading after Broadcom reported second-quarter revenue that surged on AI chip demand but issued guidance that failed to meet some investors' expectations. S&P 500 and Dow futures held near the flatline as market participants weighed geopolitical tensions in the Middle East. Several cryptocurrency- and blockchain…
Ming Shing Group Holdings Limited reported the resignation of CEO Han Yan and independent director Dongjie Lao for personal reasons, with no disagreements involved. Zhijun Pan has been appointed as interim CEO, and the company is searching for a permanent replacement. Additionally, Tianhang Zhao has been re-designated as chairman of the compensatio…
Futu, the Hong Kong-based online brokerage, said it will prevent Chinese mainland investors from opening new positions, adding to existing positions, and transferring funds into accounts beginning June 12. The announcement follows regulatory action from mainland authorities targeting cross-border securities services offered without local approval. …
Coca-Cola's finance chief said the company is adapting packaging and pricing to keep products affordable amid uneven demand across income groups, and warned the unclear outlook in the Middle East will remain a boardroom topic into 2027. Management said it is managing disruption from the U.S.-Israeli war on Iran without fear, while noting some consu…
Coca-Cola is adjusting product formats and price tiers to keep drinks accessible as consumer spending patterns diverge by income level, CFO John Murphy said at the Deutsche Bank consumer conference in Paris. The company, which raised its annual profit outlook in April, is managing disruption tied to the U.S.-Israeli war on Iran and sees the geopoli…
Vlad Yatsenko, Revolut's co-founder and current chief technology officer, will step down from his executive role in July and transition to a non-executive director position on the company's board. Donato Lucia, presently Revolut's head of technology, will assume leadership of the technology function under the new title of vice president of technolo…
Atour Lifestyle (ATAT) has the ingredients for another leg higher: rapid room rollouts, double-digit revenue growth, a shareholder-friendly capital allocation push and an upcoming dividend distribution. Technicals are mixed today, but a disciplined entry around the $35 area with a tight stop and a target near the 52-week highs gives a favorable ris…
During a joint press appearance in Stockholm, Sweden's Defence Minister Pal Jonson said Brazil has indicated interest in possibly purchasing an additional 20 Gripen E and F fighters from Saab. The planes would be manufactured in Brazil under the Embraer-Saab production arrangement that began in 2023. Brazil originally agreed to buy 36 Gripens in 20…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, completed the acquisition of a 54% interest in CliniQuantum Ltd., an Israeli company specializing in quantum simulation for clinical trial data analysis. The acquisition includes issuance of NeuroThera shares to CliniQuantum shareholders and potential earn-out payments contingent…
Biogen Inc. announced that the FDA has granted Breakthrough Therapy Designation to its investigational antisense oligonucleotide, salanersen, for treating spinal muscular atrophy (SMA). Supported by positive Phase 1b data showing motor function improvements and slowing neurodegeneration in children with SMA, salanersen offers potential high efficac…
Rezolute, Inc., a late-stage biotech company focused on treatments for refractory hypoglycemia due to hyperinsulinism, announced four presentations at the 2026 Endocrine Society Annual Meeting. These include data from the Phase 3 sunRIZE study of their drug ersodetug, which previously failed to meet primary endpoints but showed consistent glycemic …
Plus Therapeutics announced that CNSide Diagnostics, its wholly owned subsidiary, has achieved College of American Pathologists (CAP) accreditation for its Houston-based clinical laboratory. This accreditation validates the laboratory's high standards and quality controls, strengthening its position to expand the commercial use of the CNSide® CSF A…
Jade Biosciences shares plunged in pre-market trading after the company priced a sizeable secondary offering well below the prior session close. The planned sale of 10 million shares at $15.00, with a 30-day option for underwriters to buy an additional 1.5 million shares, created dilution concerns and anchored near-term price expectations, while a …
